Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald I Byrne

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
The Journal of Infectious Diseases|May 18, 2010
Chlamydia trachomatis strains and virulence: rethinking links to infection prevalence and disease severityGerald I Byrne
Proceedings of the National Academy of Sciences of the United States of America|July 2, 2003
Chlamydia uncloakedGerald I Byrne
Pathogens and Disease|April 18, 2015
Chlamydia trachomatis growth depends on eukaryotic cholesterol esterification and is affected by Acyl-CoA:cholesterol acyltransferase inhibitionJan Peters, Gerald I Byrne
Current Opinion in Microbiology|January 13, 2006
Chlamydia and programmed cell deathIsao Miyairi, Gerald I Byrne
Pathogens and Disease|June 20, 2014
Analysis of CPAF mutants: new functions, new questions (the ins and outs of a chlamydial protease)Patrik M Bavoil, Gerald I Byrne
Nature Reviews. Microbiology|September 21, 2004
Chlamydia and apoptosis: life and death decisions of an intracellular pathogenGerald I Byrne, David M Ojcius
Future Microbiology|September 12, 2013
Genetic variation in Chlamydia trachomatis and their hosts: impact on disease severity and tissue tropismHossam Abdelsamed, Jan Peters, Gerald I Byrne
Nature Reviews. Microbiology|July 14, 2004
ChlamydiaRobert Belland, David M Ojcius, Gerald I Byrne
JAMA|December 4, 2002
Chlamydia pneumoniae as an emerging risk factor in cardiovascular diseaseMurat V Kalayoglu, Peter Libby, Gerald I Byrne
Frontiers in Cellular and Infection Microbiology|March 12, 2014
Chlamydia exploit the mammalian tryptophan-depletion defense strategy as a counter-defensive cue to trigger a survival state of persistenceCarol A Bonner, Gerald I Byrne, Roy A Jensen
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
The Journal of Infectious Diseases|May 18, 2010
Chlamydia trachomatis strains and virulence: rethinking links to infection prevalence and disease severityGerald I Byrne
Proceedings of the National Academy of Sciences of the United States of America|July 2, 2003
Chlamydia uncloakedGerald I Byrne
Pathogens and Disease|April 18, 2015
Chlamydia trachomatis growth depends on eukaryotic cholesterol esterification and is affected by Acyl-CoA:cholesterol acyltransferase inhibitionJan Peters, Gerald I Byrne
Current Opinion in Microbiology|January 13, 2006
Chlamydia and programmed cell deathIsao Miyairi, Gerald I Byrne
Pathogens and Disease|June 20, 2014
Analysis of CPAF mutants: new functions, new questions (the ins and outs of a chlamydial protease)Patrik M Bavoil, Gerald I Byrne
Nature Reviews. Microbiology|September 21, 2004
Chlamydia and apoptosis: life and death decisions of an intracellular pathogenGerald I Byrne, David M Ojcius
Future Microbiology|September 12, 2013
Genetic variation in Chlamydia trachomatis and their hosts: impact on disease severity and tissue tropismHossam Abdelsamed, Jan Peters, Gerald I Byrne
Nature Reviews. Microbiology|July 14, 2004
ChlamydiaRobert Belland, David M Ojcius, Gerald I Byrne
JAMA|December 4, 2002
Chlamydia pneumoniae as an emerging risk factor in cardiovascular diseaseMurat V Kalayoglu, Peter Libby, Gerald I Byrne
Frontiers in Cellular and Infection Microbiology|March 12, 2014
Chlamydia exploit the mammalian tryptophan-depletion defense strategy as a counter-defensive cue to trigger a survival state of persistenceCarol A Bonner, Gerald I Byrne, Roy A Jensen
Pageof 3